Last Posted: Jan 31, 2019
- Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles Jodie et al. Circulation. Genomic and precision medicine 2019 Jan - Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.
Walsh Roddy et al. Genome medicine 2019 Jan 11(1) 5 - Cost Efficacy of ?-Galactosidase A Enzyme Screening for Fabry Disease.
Newman Darrell B et al. Mayo Clinic proceedings 2019 Jan 94(1) 84-88 - Prevalence of Noonan spectrum disorders in a pediatric population with valvar pulmonary stenosis.
Anderson Kailyn et al. Congenital heart disease 2018 Dec - Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield.
Thomson Kate L et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Dec - Hypertrophic cardiomyopathy: A complex disease.
Young Laura et al. Cleveland Clinic journal of medicine 2018 May 85(5) 399-411 - Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
Cirino Allison L et al. Cardiology clinics 2019 Feb 37(1) 35-43 - Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
Segura-Villalobos Federico et al. Revista espanola de cardiologia (English ed.) 2017 Jul 70(7) 604-606 - Modeling Hypertrophic Cardiomyopathy in a Dish
NIH Director's Blog, November 8, 2018 - The genetics of hypertrophic cardiomyopathy.
Akhtar Mohammed et al. Global cardiology science & practice 2018 Aug 2018(3) 36
No hay comentarios:
Publicar un comentario